Discovery of IRL 3461: a novel and potent endothelin antagonist with balanced ET A/ET B affinity

J Sakaki, T Murata, Y Yuumoto, I Nakamura…

Index: Sakaki, Junichi; Murata, Toshiki; Yuumoto, Yoko; Nakamura, Ikushi; Frueh, Thomas; Pitterna, Thomas; Iwasaki, Genji; Oda, Kyoko; Yamamura, Takaki; Hayakawa, Kenji Bioorganic and Medicinal Chemistry Letters, 1998 , vol. 8, # 16 p. 2241 - 2246

Full Text: HTML

Citation Number: 14

Abstract

IRL 3461, N-butanesulfonyl-[N-(3, 5-dimethylbenzoyl)-N-methyl-3-[4-(5-isoxazolyl)-phenyl]- alanyl]-(L)-valineamide, a potent and bifunctional (ETA+ ETB)[Ki (ETA)= 1.8 nM, Ki (ETB)= 1.2 nM] antagonist was discovered by structural modification of IRL 2500, an ETB selective antagonist. IRL 3461 was found to be stable on incubation with human, rat, mous, and guinea pig plasmas.

Related Articles:

A novel synthesis of 1, 2, 4-oxadiazoles and isoxazoles

[Kivrak, Arif; Zora, Metin Tetrahedron, 2014 , vol. 70, # 4 p. 817 - 831]

Identification and optimisation of 5-amino-7-aryldihydro-1, 4-diazepines as 5-HT 2A ligands

[Swain, Christopher J.; Teran, Ana; Maroto, Marta; Cabello, Angeles Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 23 p. 6058 - 6062]

Identification and optimisation of 5-amino-7-aryldihydro-1, 4-diazepines as 5-HT 2A ligands

[Swain, Christopher J.; Teran, Ana; Maroto, Marta; Cabello, Angeles Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 23 p. 6058 - 6062]

New synthesis of pyrazole and isoxazole derivatives

[Molina, P.; Fresneda, P. M. Journal of Heterocyclic Chemistry, 1984 , vol. 21, p. 461 - 464]

More Articles...